Valuation Indivior Pharmaceuticals, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-10 EDT			5-day change	1st Jan Change
40.50 ^USD	-1.94%		+1.76%	+12.88%

06-28	Indivior Pharmaceuticals, Inc.(NasdaqGS:INDV) added to Russell 2000 Value-Defensive Index	CI
06-28	Indivior Pharmaceuticals, Inc.(NasdaqGS:INDV) added to Russell 2000 Growth-Defensive Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,423	2,969	2,085	1,553	4,480	4,938	-	-
Change	-	22.54%	-29.76%	-25.5%	188.39%	10.23%	-	-
Enterprise Value (EV) ¹	1,563	2,435	2,008	1,567	4,604	4,992	4,534	4,010
Change	-	55.81%	-17.52%	-21.95%	193.72%	8.44%	-9.17%	-11.57%
P/E	12.8x	-57.2x	1,527x	-34.5x	21.9x	12.8x	11.2x	10.4x
PBR	-	59.3x	-	-8.02x	-45.8x	-	-	-
PEG	-	0x	-15x	0x	-0x	0.1x	0.8x	1.29x
Capitalization / Revenue	3.06x	3.29x	1.91x	1.31x	3.62x	3.93x	3.78x	3.59x
EV / Revenue	1.98x	2.7x	1.84x	1.32x	3.72x	3.97x	3.47x	2.92x
EV / EBITDA	7.74x	10.8x	6.97x	4.64x	10.8x	7.65x	6.57x	5.58x
EV / EBIT	8.36x	11.5x	7.47x	5.02x	11.1x	8.01x	6.83x	5.74x
EV / FCF	4.61x	-10.7x	-4.86x	-196x	-49.5x	13.9x	9.35x	7.45x
FCF Yield	21.7%	-9.32%	-20.6%	-0.51%	-2.02%	7.22%	10.7%	13.4%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	1.35	-0.38	0.01	-0.36	1.64	3.175	3.61	3.9
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	791	901	1,093	1,188	1,239	1,258	1,308	1,374
EBITDA ¹	202	225	288	338	428	652.9	690.5	718.4
EBIT ¹	187	212	269	312	415	623.3	664	698.8
Net income ¹	205	-53	2	-48	210	414.5	472.9	517.4
Net Debt ¹	-860	-534	-77	14	124	54.5	-403.4	-928
Reference price ²	17.25	21.75	15.27	12.43	35.88	40.50	40.50	40.50
Nbr of stocks (in thousands)	140,437	136,489	136,551	124,970	124,854	121,922	-	-
Announcement Date	2/16/22	2/16/23	2/22/24	2/20/25	2/26/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
INDIVIOR PHARMACEUTICALS, INC.	12.76x	3.97x	7.65x	-	4.94B
ELI LILLY AND COMPANY	34.92x	12.63x	25.81x	0.57%	1,060B
JOHNSON & JOHNSON	27.42x	6.3x	17.1x	2.08%	619B
ABBVIE INC.	30x	7.34x	15.02x	2.76%	438B
ROCHE HOLDING AG	17.98x	4.45x	11.01x	2.97%	333B
NOVARTIS AG	21.52x	5.52x	13.36x	2.86%	282B
ASTRAZENECA PLC	21.56x	4.53x	12.65x	1.94%	267B
NOVO NORDISK A/S	14.17x	5.3x	10.9x	3.52%	218B
AMGEN INC.	23.77x	6.31x	11.12x	2.78%	196B
GILEAD SCIENCES, INC.	-46.02x	5.6x	31.12x	2.5%	161B
Average	15.81x	6.19x	15.57x	2.44%	357.88B
Weighted average by Cap.	23.84x	7.84x	18.15x	2%